This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
If you can join us in DC on May 18th and 19th, please register today ! If you would like to participate in Lobby Day remotely, please complete the form below, and we will deliver your message to your representatives.
This year marks 23 years since Americans for Safe Access (ASA) first opened its doors, driven by a personal mission and a collective vision to improve lives through medical cannabis. My own journey with therapeutic cannabis inspired the founding of ASA in 2002, and since then, I've witnessed firsthand how patient advocacy can profoundly change healthcare and people's lives.
I am so excited about this project! This is not all the Women Who Crush, but I had to stop myself after 40 interviews to get other work done. (I am already working on my list for Season 2, which will focus on ASA Advocates.) ASA Presents: A limited web series: Women Who Crush: Shedding Light on How Sh*t Gets Done: Real conversations with powerhouse womenabout their work, impact, and what drives them.
By now, it is a common refrain: the weed is getting stronger. Recent research backs this up. For example, data from the National Institute on Drug Abuse reveal that the level of THC in cannabis samples seized by law enforcement averaged 4% in 1995. By contrast, in 2022, the average level of THC was upwards of 16%.
As someone who has been a medical cannabis advocate for over 2 decades, Ive been watching the return of a Trump administration with caution. Many had high hopes for what another term might mean for cannabis. During the 2024 election, Trump expressed support for cannabis rescheduling and patient access, and even said he intended to vote for the legalization measure on the Florida ballot.
Thank you to the 200+ folks who joined us last night! For everyone else, here is the recap: In the meeting, we discussed ASA's ZERO tolerance policy on Federal interference in the medical cannabis programs. The CJS amendment means that the states, territories, or the District of Columbia, handle any matters surrounding medical cannabis operators,patients, and caregivers PERIOD.
People are always amazed when I tell them I have been in the medical cannabis issue for almost 50 years. In August 1975, my late husband, Robert Randall, and I were busted for marijuana cultivation and possession. Thankfully, it was only a misdemeanor charge. We could have paid a fine and been done with it. But there was a complication. Robert had glaucoma, and cannabis was saving his sight.
Join us in DC: May 18-19, 2025 Join advocates in our nation's capital for a day of skill and community-building workshops, followed by meetings with your federal representatives. Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Join us in DC: May 18-19, 2025 Join advocates in our nation's capital for a day of skill and community-building workshops, followed by meetings with your federal representatives. Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Special guest Crista Egger updates us from the frontline! Crista Eggers is deeply committed to the advocacy and advancement of medical cannabis legalization in Nebraska. Crista's passion for advocacy began when her youngest son, Colton, was diagnosed with intractable epilepsy just after he turned two. After exhausting all medications and available treatment options for Colton, his doctors mentioned medical cannabis treatment.
Americans for Safe Access members were at the Ohio State House on March 20th to remind policymakers to prioritize Ohio medical cannabis patients as they consider cannabis legislation this session. Ohio legislators have been at odds with voters after they overwhelmingly supported cannabis legalization at the ballot box in November 2023 by passing Issue 2.
With over 20 years of experience, Ive dedicated my career to advancing cannabis policy and patient rights. One of the most impactful ways we drive change is through direct advocacy. Thats why I am joining ASA members and cannabis advocates across California for the California NORML/Americans for Safe Access Citizen Lobby Day on Monday, March 24, in Sacramento.
While Schedule III may seem like a large deviation from the recommendations provided by HHS and DEA in 2016, outright dismissing the finding of HHS and DOJ, currently accepted medical use does not take into account the enormity of the scientific and medical discoveries that have happened in the time since they were issued as well as the vast societal call for an updated approach to cannabis policy.
How to Participate in Medical Cannabis Awareness Week Medical Cannabis Awareness Week is an opportunity to educate and alert your network about the challenges facing medical cannabis patients and ways they can get involved. Tune in & learn how you can join advocates across the U.S. and make some noise for change in 2025! Sign-up: www.SafeAccessNow.org/mcaw_2025 Please subscribe to ASA's YouTube Channel!
Feb 15-22, 2025, is Medical Cannabis Awareness Week! This is a time for medical cannabis advocates to better educate themselves and their communities about all things medical cannabis. We have created this playlist to highlight some of the resources we have on the Americans for Safe Access YouTube Channel. Pick or choose or explore other playlists. Happy Medical Cannabis Awareness Week!
By Nikki Lawley & Oleg Maryasis, MS Medical cannabis patients in New York face unnecessary financial and accessibility barriers that limit their ability to receive the care they need. On March 11, 2025, we invite patients, advocates, healthcare professionals, and concerned citizens to join us in Albany for the Medical Cannabis Lobby Day an opportunity to push for meaningful reforms that will enhance patient access and ensure New Yorks medical cannabis program prioritizes those who rely on it
Playing Defense in the 119th Congress The 2024 Elections shook up leadership in the administration and in Congress, putting a cohort of anti-cannabis representatives in positions that could significantly impact gains to patient access from medical cannabis programs and hemp markets. Tune in and get prepared for defensive organizing strategies in the upcoming months.
Offensive Strategies for Medical Cannabis Policy in the 119th Congress Key milestones achieved by the medical cannabis movement in the last few years and the shake-up in D.C. following the 2024 elections could mean a national medical cannabis program is closer than ever. However, advancing medical cannabis policy will require strategic campaigning and disciplined movement building.
WELCOME TO ASAS FIRST 100 DAYS CAMPAIGN! The first 100 days of the 47th Administration and 119th Congress will set policy priorities that impact millions of patients across America. From the economy to housing and public health, these decisions will shape the direction of medical cannabis policy for years to come. The only way to ensure these changes truly benefit patients is to make our voices heard!
Americans for Safe Access Lunch & Learn Webinar Series-1/22/25 How to get involved with ASA's First 100 Days Campaign Policy priorities will be set in the first 100 days of the 47th Administration and 119th Congress for the upcoming year. Tune in and learn how you can get involved!
DEA Postponed Rescheduling Hearing, What Just Happened? Join ASA staff as we dive into the new ruling to postpone the DEA hearings, what it means for the current rescheduling process, and where we go from here. SafeAccessNow.
As a pediatric emergency department pharmacist, I witness both the incredible potential of modern medicine and some of its most glaring gaps. One of those gaps is medical cannabis, which, in my opinion, is a tremendously underutilized tool. Even among the sickest and most vulnerable patients I see, I often find myself wondering: Could medical cannabis help this person?
Nearly two decades ago, we founded Americans for Safe Access (ASA) to bring patients needs and voices out of the shadows and into the center of the national cannabis debate. Back then, patients were criminalized, stigmatized, and rarely heardtrotted out in courtrooms or used as talking points, then shut out of actual policy decisions. Our work at ASA began out of necessity: patients like myself needed recognition, protection, and a clear path to safely and legally access life-changingand in many
Americans for Safe Access Founder Steph Sherer Returns to Lead the Initiative Washington, D.C. Americans for Safe Access (ASA) is proud to announce the return of its founder, Steph Sherer, to the position of Executive Director. Sherer will lead a renewed, nationwide effort to fully integrate cannabis-based medicines into the U.S. healthcare system.
On Monday, December 2, 2024, at 9:30 a.m., formal hearings begin regarding the Department of Justice's (DOJ) notice of proposed rulemaking (NPRM) to move cannabis to Schedule III. The hearing will be live streamed: www.DEA.gov/live.
The Notice of Proposed Rulemaking (NPRM) and the Drug Enforcement Administration's (DEA) General Notice of Hearing (GNoH) state : "The purpose of a hearing would be to receive factual evidence and expert opinion regarding whether marijuana should be transferred to Schedule III of the list of controlled substances.Upon reviewing the Notice of Proposed Rulemaking (NPRM) and the Office of Legal Counsel (OLC) memorandum titled "Questions Related to the Potential Rescheduling of Marijuana," it become
While Presidential candidates’ positions on cannabis may make for good headlines, the reality is that, aside from signing legislation and directing federal agencies, the office of the President of the United States (POTUS) does not have the power to fundamentally change cannabis laws. Even the rescheduling process currently in the hands of the DEA, resisting the move to Schedule III, will be out of reach of President Trump’s influence.
Join ASA Staff, Advisors, Chapters, Members, & Affiliates for this post-election webinar. We will discuss the impacts of the election, a potentially jam-packed lame-duck session, National Days of Action, the DEA rescheduling hearings, and preparing for the 47th president & 119th Congress.
TAKE A BREATH The Administrative Law Judge recently postponed the DEA’s highly anticipated rescheduling hearing and released the DEA’s witness list, prompting speculation, conspiracies, and anxiety about the delay and the agency’s next moves. Before you pull your hair out, read these five essential points to put your mind at ease. With your hair intact, you can focus on the one area where you can impact rescheduling—(wait for it).
We are happy to present you with the Election Edition of the ASA Monthly Newsletter! Americans for Safe Access launched the Compassionate Candidate Campaign to provide candidates in the 468 Congressional races in the 2024 Election information on policies that will improve the lives of medical cannabis patients. With one week until the election, ASA has put together this special edition of that ASA monthly newsletter to bring you the information you need on November 5th.
This election year, Capitol Hill buzzed with discussions about cannabis scheduling, hemp regulations, and the FDA’s evolving role in regulating cannabinoids. Yet, missing from these debates was one critical topic: the future of medical cannabis and protections for patients. As we head toward the 2024 election, it’s clear that cannabis policies will shift in the next Congress, impacting the lives of patients and families across the nation.
Americans for Safe Access (ASA) has been at the forefront of fighting for patients’ rights to access medical cannabis across four presidencies since our founding in 2002. We've crafted briefing materials and “100-day campaigns” for three incoming administrations on medical cannabis policy. Over the years, we’ve learned what a president can—and, more importantly, cannot—do to shape cannabis policy.
Americans for Safe Access (ASA) has been at the forefront of fighting for patients’ rights to access medical cannabis across four presidencies since our founding in 2002. We've crafted briefing materials and “100-day campaigns” for three incoming administrations on medical cannabis policy. Over the years, we’ve learned what a president can—and, more importantly, cannot—do to shape cannabis policy.
On September 26th, medical cannabis advocates from Hawaii to Florida gathered on Capitol Hill for the Validated Voices Summit, representing patients from across the nation. It marked a pivotal moment as patients met in Washington, DC, for the first time since the Department of Health and Human Services (HHS) and the Department of Justice (DOJ) acknowledged that cannabis has accepted medical use in the United States.
(Image from the Cathy Jordan Movie Facebook Page) The world has lost a remarkable advocate and beloved friend in Cathy Jordan, who passed away on July 4th at her home in South Florida at the age of 74. Her life was a testament to courage and resilience, and her legacy as a pioneer in the fight for medical cannabis rights will continue to inspire countless individuals.
Guest Blog: by Jennifer Douglas, Founder Homegrown4Heroes In recent months, the cannabis community supporting veterans through Homegrown4Heroes (HG4H) has faced an unprecedented challenge. Hurricane Helene, a powerful and destructive storm, ravaged vast portions of the East Coast, leaving behind a path of devastation, not only in homes and infrastructure but also in the green fields where HG4H’s growers cultivate their crops.
ASA's Monthly Newsletter! Back by popular demand, we are proud to bring you the ASA Monthly Newsletter! We can only continue to do this important work with your support, consider becoming an ASA member today! ASA has recently revamped our Member Benefits Program, adding new benefits for our members each month like the 20% off offer on Nectar Products (see article below on Nectar) & 50% off registration for the upcoming Validated Voices Summit in September.
Join Americans for Safe Access (ASA) for a Roundtable discussion on cannabis product recalls with key stakeholders to discuss the basics of recalls, how they work, what they mean for patients and consumer health, and why they signal a functioning cannabis regulatory system.
Americans for Safe Access (ASA) fully supports the regulation of cannabinoid products as part of our mission to ensure safe access for patients, and we want you to be successful in your efforts to do so in California. We have consistently called for federal oversight of these products and supported the spirit of AB 2223 but requested a minor yet crucial amendment to address a major issue affecting some of California’s most vulnerable residents.
For Immediate Release: September 5, 2024 AMID RECENT CANNABIS RECALLS, AMERICANS FOR SAFE ACCESS RELEASES CRITICAL REPORT: "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety" Washington, D.C. – Following a concerning series of cannabis recalls due to contamination, Americans for Safe Access (ASA) announced the release of a crucial new resource today: " What’s in Your Cannabis?
By Doug Henry for Mother Jones One seller claims Gold Coast Clear is “working hard to keep their customers safe,” and that “these verified cartridges have undergone various lab tests approved by CannaSafe.” Of course, that language doesn’t say they were actually tested by CannaSafe. Indeed, that lab closed in 2022, largely, according to former president Antonio Frazier, because “lab shopping” clients went elsewhere seeking more positive results.
By Kate Robertson for MJBizDaily State marijuana regulators, producers and other stakeholders are grappling with how to safeguard consumers at a time when lab-testing requirements and enforcement differ dramatically nationwide and large-scale product recalls are common. Each state currently takes its own approach to medical and adult-use cannabis lab testing for potency and contaminants as well as production standards and inspection – a situation that has led to inconsistent testing regulations
By Hannah LaClaire for the Portland Press Herald Steph Sherer, founder of medical cannabis advocacy group Americans for Safe Access, stressed during the panel Tuesday that contaminants are often an innocent mistake. “It doesn’t mean that there’s someone who has some evil plan to contaminate patients,” she said. Cannabis is a bioaccumulator, meaning it will suck up and hold onto any pesticides and heavy metals in the soil.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content